Explore how IMCD's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 5.2% p.a. on average ...

Kepler Capital analyst Matthias Maenhaut maintained a Buy rating on IMCD N.V. (0QVU – Research Report) on March 10 and set a price target of ...

ROTTERDAM, The Netherlands (3 March 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner and formulator of speciality chemicals and ingredients, today announced it has ...

The patient, who is remaining anonymous, has idiopathic multicentric Castleman's disease (iMCD), which has an especially poor survival rate and few treatment options. But an AI tool searched ...

In a report released on March 5, Matthias Maenhaut from Kepler Capital maintained a Buy rating on IMCD N.V. (0QVU – Research Report), with a ...

SINGAPORE: IMCD Group, a leading speciality chemicals and food ingredients company, has acquired the pharmaceutical ingredients business of Maxwell Pharma Sdn Bhd, a family-owned Malaysian company.

A press release from Penn Medicine News explained that iMCD is a cytokine storm disorder “in which too many inflammatory cytokines … are released and can damage the body’s tissues and organs.” ...

Rotterdam, The Netherlands (5 March 2025) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its full ...

IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner and formulator of speciality chemicals and ingredients, today announced it has committed to the Science Based Target initiative ...